|
TCTN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.139800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.016800E-01 |
| Normal-vs-Stage2 |
2.176800E-01 |
| Normal-vs-Stage3 |
6.010800E-01 |
| Normal-vs-Stage4 |
1.722150E-01 |
| Stage1-vs-Stage2 |
4.071400E-01 |
| Stage1-vs-Stage3 |
9.112800E-01 |
| Stage1-vs-Stage4 |
1.768570E-01 |
| Stage2-vs-Stage3 |
5.952400E-01 |
| Stage2-vs-Stage4 |
5.547800E-01 |
| Stage3-vs-Stage4 |
3.393400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.498500E-02 |
| Normal-vs-AfricanAmerican |
8.541600E-02 |
| Normal-vs-Asian |
9.766000E-01 |
| Caucasian-vs-AfricanAmerican |
6.203400E-01 |
| Caucasian-vs-Asian |
6.954600E-01 |
| AfricanAmerican-vs-Asian |
7.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.287600E-01 |
| Normal-vs-Female |
5.975900E-04 |
| Male-vs-Female |
7.394300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.296800E-01 |
| Normal-vs-Extreme_Weight |
9.303600E-01 |
| Normal-vs-Obese |
1.482180E-01 |
| Normal-vs-Extreme_Obese |
8.323000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.124800E-01 |
| Normal_Weight-vs-Obese |
4.261600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.312200E-01 |
| Extreme_Weight-vs-Obese |
1.530640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.535000E-01 |
| Obese-vs-Extreme_Obese |
3.705200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.019800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.250310E-02 |
| Normal-vs-Age(61-80Yrs) |
4.414600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.286400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.167200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.797600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.609500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.227600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.461600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.980400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.925600E-02 |
| Normal-VS-Type2 PRCC |
8.694600E-01 |
| Normal-VS-KIRP CIMP |
5.918100E-02 |
| Normal-VS-Unclassified PRCC |
1.315210E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.789230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.286200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.946400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.149790E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.599190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.791610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.483000E-01 |
| Normal-vs-N1 |
1.041960E-01 |
| Normal-vs-N2 |
4.901200E-01 |
| N0-vs-N1 |
5.874500E-02 |
| N0-vs-N2 |
3.799200E-01 |
| N1-vs-N2 |
9.195000E-01 |
|
|
